We are live on ! Find out more
LMAT icon

LeMaitre Vascular
LMAT

182 hedge funds and large institutions have $872M invested in LeMaitre Vascular in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 59 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

5% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 59

0.82% more ownership

Funds ownership: 84.8% → 85.62% (+0.82%)

1% more funds holding

Funds holding: 181 → 182 (+1)

6% less capital invested

Capital invested by funds: $929M → $872M (-$56.3M)

92% less call options, than puts

Call options by funds: $529K | Put options by funds: $6.89M

Holders
182
Holders Change
+1
Holders Change %
+0.55%
% of All Funds
2.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
62
Reduced
59
Closed
27
Calls
$529K
Puts
$6.89M
Net Calls
-$6.36M
Net Calls Change
+$3.36M

Top Buyers

Rank Fund Capital Flow
1
VOYA Investment Management
VOYA Investment Management
Georgia
+$14.7M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.86M
3
Millennium Management
Millennium Management
New York
+$2.84M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.86M
5
BlackRock
BlackRock
New York
+$1.25M

Top Sellers

Rank Fund Capital Flow
1
Amundi
Amundi
France
-$3.63M
2
State Street
State Street
Massachusetts
-$1.6M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.23M
4
ETC
Exchange Traded Concepts
Oklahoma
-$1.15M
5
KCM
Kennedy Capital Management
Missouri
-$1.09M

LMAT Hedge Fund Activity: Q1 2022 in Review

182 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2022, worth a combined $872M — down 6.1% from $929M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new LMAT positions and 27 closed out — a net gain of 4 holders — while 62 added to existing stakes and 59 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $14.7M. The largest seller was Amundi, cutting an estimated $3.63M.

  • 182 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2022, up from 181 in Q4 2021.
  • Funds reported $872M of LeMaitre Vascular stock for Q1 2022, down 6.1% quarter-over-quarter.
  • 31 funds opened new LeMaitre Vascular positions in Q1 2022 and 27 closed out, a net change of +4 holders.
  • The largest LeMaitre Vascular buyer in Q1 2022 was VOYA Investment Management, an estimated $14.7M added.
  • The largest LeMaitre Vascular seller in Q1 2022 was Amundi, an estimated $3.63M sold.

Based on aggregated 13F filings for Q1 2022.